QT
MAZE

Quantbot Technologies’s Maze Therapeutics MAZE Stock Holding History

Quantbot Technologies’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,221
Closed -$216K – 2252
2025
Q4 		$216K Buy
+5,221
New +$179K 0.01% 1215

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Quantbot Technologies's MAZE Position: Q1 2026 in Review

Quantbot Technologies sold out of Maze Therapeutics (MAZE) in Q1 2026, closing a stake of 5,221 shares — an estimated $216K sold.

Quantbot Technologies first reported a position in MAZE in Q4 2025 and held it in 1 quarter. The position peaked at $216K in Q4 2025. 165 funds tracked by Wall St. Rank hold MAZE as of Q1 2026.

  • Quantbot Technologies reported no remaining Maze Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 5,221 Maze Therapeutics shares in Q1 2026, an estimated $216K.
  • Quantbot Technologies first reported a position in Maze Therapeutics in Q4 2025 and held it in 1 quarter.
  • Quantbot Technologies's Maze Therapeutics position peaked at $216K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Maze Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.